Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis.
Shah A, Jones MP, Callaghan G, Fairlie T, Ma X, Culver EL, Stuart K, De Cruz P, O'Beirne J, Tabibian JH, Dignass A, Canbay A, Gores GJ, Holtmann GJ.
Shah A, et al. Among authors: ma x.
Hepatol Commun. 2024 Jan 11;8(1):e0347. doi: 10.1097/HC9.0000000000000347. eCollection 2024 Jan 1.
Hepatol Commun. 2024.
PMID: 38206197
Free PMC article.